Answers are grounded in this paper and cite their sources.
Integrative oncology (IO) programs are committed to offer evidence-based complementary medicine within conventional cancer care, addressing quality of life-related concerns. As part of a multidisciplinary team, clinical pharmacists provide guidance on potential effectiveness and safety of herbal supplement use, identifying potential toxicities and herb-drug interactions. In this commentary, we discuss the need to establish clinical competencies based on a structured training syllabus addressing patients' preferences and expectations, while ensuring safe IO practices.
No takes yet. Share an insight, caveat, or question.
Ben‐Arye et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: